GlassScriptPhysician profile
Hima B Lingam
NPI 1548451776
$1,625.50
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,403 · 2020: $195 · 2021: $27.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $955.01 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $236.27 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $85.53 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $44.39 | 2019-2020 | |
| Amgen INC. | $41.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.14 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.50 | 2019 | |
| Genentech USA, INC. | $30.09 | 2019-2021 | |
| Exelixis INC. | $23.79 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.61 | 2019 | |
| Eisai INC. | $22.15 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.12 | 2019 | |
| Astellas Pharma US INC | $15.60 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $15.28 | 2019 | |
| Novocure INC. | $14.37 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $14.04 | 2020 | |
| Fortovia Therapeutics, INC. | $12.59 | 2020 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hima Lingam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.